Brown Advisory’s AstraZeneca AZN Stock Holding History

Brown Advisory's AZN Position: Q2 2026 in Review

Brown Advisory increased its AstraZeneca (AZN) stake by 0.08% in Q2 2026, buying an estimated $1.5K and bringing the position to 10,388 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Brown Advisory first reported a position in AZN in Q4 2017 and has held it in 22 quarters since. The position peaked at $2.05M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

• Brown Advisory held 10,388 shares of AstraZeneca worth $1.97M as of Q2 2026.
• Brown Advisory bought 8 AstraZeneca shares in Q2 2026, an estimated $1.5K.
• AstraZeneca made up ﹤0.01% of Brown Advisory's portfolio in Q2 2026, its #729 holding.
• Brown Advisory first reported a position in AstraZeneca in Q4 2017 and has held it in 22 quarters since.
• Brown Advisory's AstraZeneca position peaked at $2.05M in Q1 2026.
• 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.